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Abstract 
Objective: To prove the effectiveness of Curcuma longa to prevent damage  cells  by analyzing  FOXP3 gene 
expression, TNF-α level, and histopathology of placental tissue.  
Methods: This study was conducted in 20 early pregnant mice, divided in 5 groups (K1-K5). K1-K4 were injected 
with  tachyzoites. K1 and K2 were intervened with Curcuma longa 125  and 500 mg/kg/day. K3 were intervened 
with  spiramycin  60 mg/kg/day, K4 were intervened with 0,2 distilled water, and  K5 was not injected and 
intervened. IgG-IgM levels, FOXP3 mRNA expression, TNF-α level was examined serially, and  placental mice 
were taken for histopathology examination  7 days after intervention.
Results:  FOXP3 mRNA expression in K1 and K2  increased significantly 7 days after intervention compared to 
K4 (p < 0.05), however the increased  of  expression in two groups has no significant difference. TNF-α level in 
K1 and K2 decreased significantly 7 days after intervention compared to K4  (p < 0.05), however the decrease of 
level in two groups has no significant difference. Hemorrhagic and necrotic cells were not found in K1 and K2, but 
were found in  K3 (75%)  and K4 (100%). 
Conclusion: Curcuma longa 125 mg is effective to prevent cells damage in early pregnant mice with acute 
toxoplasmosis. 
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Efektivitas Ekstrak Curcuma Longa Mencegah Kerusakan Sel Pada Mencit 
Hamil Muda dengan Toksoplasmosis Akut.
Abstrak
Tujuan: Membuktikan efektivitas Curcuma longa  mencegah kerusakan sel dengan menganalisis ekspresi gen 
FOXP3, kadar TNF-α, dan histopatologi jaringan plasenta.
Metode: Penelitian dilakukan pada 20 tikus hamil muda, dibagi dalam 5 kelompok (K1-K5). K1-K4 diinjeksi 10 
takizoid toksoplasma intra abdominal. Tiga hari pasca injeksi takizoid, K1 dan K2 diintervensi dengan Curcuma 
longa 125 dan 500 mg / kg / hari. K3 diintervensi dengan spiramisin 60 mg / kg / hari, K4 diintervensi dengan 0,2 
ml air suling dan K5 tidak diinjeksi dan tidak diintervensi. Kadar  IgG-IgM, ekspresi mRNA FOXP3, kadar TNF-α 
diperiksa secara serial  dan  plasenta tikus  diambil untuk pemeriksaan histopatologi  7 hari pasca intervensi.
Hasil: Ekspresi mRNA FOXP3 pada K1 dan K2 meningkat bermakna (p< 0.05)  7 hari pasca intervensi 
dibandingkan dengan K4 (p <0,05), tetapi peningkatan ekspresi pada kedua kelompok tidak terdapat perbedaan 
bermakna. Kadar TNF-α pada K1 dan K2 menurun bermakna 7 hari pasca intervensi dibandingkan dengan K4 (p 
<0,05), tetapi  penurunan kadar pada dua kelompok tidak terdapat perbedaan  bermakna. Hemoragik dan nekrotik 
sel tidak ditemukan pada K1 dan K2, tetapi ditemukan pada K3 (75%) dan K4 (100%).
Kesimpulan: Curcuma longa 125 mg efektif untuk mencegah kerusakan sel pada tikus hamil muda dengan 
toksoplasmosis akut.
Keywords: Curcuma longa, kerusakan sel, hamil muda, gene FOXP3, TNF-α, toxoplasmosis
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Introduction 
Toxoplasmosis is an infection caused by the 
parasite toxoplasma gondii1-3. Toxoplasma 
infection will stimulate the cellular and 
humoral immune response of the body4-6. 
The Fork head box P3 (FOXP3) gene as a 
regulator of the balance of cellular immunity 
through T- helper cell7.  The role of FOXP3 
gen   is to suppress T helper cells especially 
Th1 (TNF-α) 8. When the infection occurs, 
FOXP3 gene expression decreases and the 
TNF-alpha levels increase 9,10. An excessive 
increase of TNF-alpha levels can cause 
thrombosis, ischemia, and necrotic cells. If 
this condition occurs in early pregnancy, it 
can cause damaged cells and abortion11-13
Curcuma longa is a plant that belongs to 
the rhizome group that is easy to grow and 
found in Asia. Curcuma longa from ancient 
times has been used as a traditional medicine 
and herbal therapy. Curcumin is a major 
component of curcuma longa has been widely 
studied for its potent anti-inflammatory14, 
anti-oxidant15, anti-parasite16, and anti-micro 
organism17, 18. This study aims to prove the 
effectiveness of curcuma longa extract to 
prevent the cell damage of placental tissue in 
early pregnant mice with acute toxoplasmosis 
by analyzing the expression of foxp3 mRNA, 
TNF-α levels and histopathology examination 
of placental mice after intervention.
Material and  Methods  
This research is  experimental pre and post- 
test control groups design  using 20  Balb/c 
female mice that were conditioned into 1-3 
day(s) pregnancy that fulfill inclusion criteria 
(mice age 9-11 weeks, weigh 17- 20 grams, 
willing to eat and drink). The early pregnant 
mice were divided into five groups (K1 
– K5), 4 mice each group. K1 – K4 were 
injected with 10 tachyzoites of T. gondii 
RH strain intra-peritoneal, and K5 without 
infection.  The Curcuma longa extract get 
use was obtained by maceration, and the 
curcuminoid compound was evaluated using 
KLT densitometry and spectrophotometry. 
Curcuminoid level in C. longa extract 
obtained were at 25.5%. Three days after 
injection of tachyzoites, K1 and K2 were 
each given C. longa extract dose of 125 and 
500 mg/kg/day, K3 was given spiramycin 
dose of 60 mg/kg/day (positive control), K4 
was given 0.2 ml distilled water (negative 
control), and K5 was not intervention.  Each 
intervention was administered for 7 days. 
Blood samples were taken serially (one 
day before tachyzoites injection, 3 days after 
tachyzoites injection, and 3 days and 7 days 
after intervention). Examination of anti-
toxoplasma IgG-IgM antibody levels and 
TNF-α level were examined using enzyme-
linked immune-sorbent assay (ELISA), 
(Qualitative mouse toxoplasma antibody IgG 
(T-IgG) ELISA Kit Cat. No: MBS9310461 and 
Qualitative mouse toxoplasma antibody IgM 
(T-IgM) ELISA Kit Cat. No: MBS9310461) 
and The level of TNF-α was determined with 
ELISA Kit (LS-Bio: Life-Span Bio-Sciences, 
Inc. FOXP3gene expression by Quantitative 
Real-time polymerase chain reaction 
(q-PCR). Quantitative Real-time polymerase 
chain reaction (q-PCR) examination was 
performed using a PCR system (Applied 
Bio-system-Rad BT004129 USA machine) 
used SYBR power Green PCR Mix. FOXP3 
primer is : FW-TTT ACT CGC ATG TTG 
CCT ACTT and RV- TCA AAT  TCA TCT 
ACG GTC CAC ACT (NM_ 001199347.1), 
and standard of normality is  GAPDH  FW-
CAT GGC CTT CCG TGT TCCT AND RV-
GCG GAC GTC AGA TCCA (M32599.1). 
The examination of FOXP3 expression 
according to the standard procedure of 
q-PCR. The expression of the FOXP3 gene 
is inferred in the form of numbers seen on the 
computer monitor screen. Seven days after 
the intervention, the mice were sacrificed to 
remove the uterus containing the placenta. 
Examination of placental histopathology in 
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all samples was done to study and assessed 
the degree of damage of placental tissue in the 
form of the congestive capillary, extracellular 
edema, hemorrhagic and necrotic cells.
     The data were processed using SPSS 
software and the data were statistically 
analyzed using paired t-test to determine the 
TNF-α level and FOXP3 gene expression 
before and after intervention.  One-way Anova 
test was conducted to determine the difference 
of TNF-α level, and FOXP3 gene expression 
among these 5 groups.  Histopathology 
finding were reported in percentage, and chi-
square test was performed to identify cells 
damage between groups.  A values of p <0.05 
was considered significant. 
Results 
Table 1   Anti-Toxoplasma IgM Antibody Level before and after Intervention.
 Group
 (K)
    Anti-Toxoplasma  IgM Antibody level Cut  Off 
Point (OD)A1 A2 A3 A4
K1 0,250 ± 0,001 0,847 ± 0,012 0,534 ± 0,013 0,346 ± 0,024
        0,327
K2 0,260 ± 0,017 0,828 ± 0,010 0,517 ± 0,005 0,321 ± 0,009
K3 0,242 ± 0,011 0,795 ± 0,012 0,564 ± 0,013 0,355 ± 0,014
K4 0,251 ± 0,011 0,826 ± 0,017 1,434 ± 0,021 1,629 ± 0,015
K5 0,249 ± 0,007 0,302 ± 0,012 0,266 ± 0,013 0,307 ± 0,018
Legend. K1: Group injected with tachyzoites and intervered  with C. Longa  dose of  125 mg/kgbb. K2: Group injected with 
tachyzoites and intervered  with C. Longa  dose of  500 mg/kgbb. K3: Group injected with tachyzoites and intervered  with 
Spiramycin  dose of  60 mg/kgbb. K4: Group injected with tachyzoites and intervered  with distilled water 0,2 ml. K5: Group 
was not injected with tachyzoites and  was not intervered.   A1:one day before tachyzoites injection, A2: Three days after 
tachyzoites injection, A3 and A4 Three and seven days after intervention. 
 Table 2   Anti-Toxoplasma IgG Antibody Level before and after Intervention. 
Group
(K)
Anti-Toxoplasma  IgG Antibody level Cut Off point
(OD)A1 A2 A3 A4
K1 0,162 ± 0,008 0,348 ± 0,015 0,449 ± 0,023 0,441 ± 0,013
0, 302
K2 0,153 ± 0,006 0,362 ± 0,021 0,462 ± 0,012 0,455 ± 0,008
K3 0,154 ± 0,010 0,340 ± 0,008 0,439 ± 0,004 0,461 ± 0,021
K4 0,155 ± 0,009 0,354 ± 0,010 0,753 ± 0,007 1,365 ± 0,009
K5 0,132 ± 0,012 0,154 ± 0,010 0,152 ± 0,015 0,139 ± 0,015
Legend. K1: Group injected with tachyzoites and intervered  with C. Longa  dose of  125 mg/kgbb. K2: Group 
injected with tachyzoites and intervered  with C. Longa  dose of  500 mg/kgbb. K3: Group injected with tachyzoites 
and intervered  with Spiramycin  dose of  60 mg/kgbb. K4: Group injected with tachyzoites and intervered  with 
distilled water 0,2 ml. K5: Group  was not injected with tachyzoites and  was not intervered.   A1:one day before 
tachyzoites injection, A2: Three days after tachyzoites injection, A3 and A4 Three and seven days after intervention. 
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Table 3   FOXP3 Gene Expression before and after Intervention.
Group
(K)
FOXP3 Gene Expression
          A1            A2         A3         A4
K1 9,98 ± 0,14 7,98 ± 0,21 12,03 ± 0,13 9,88 ± 0,23
K2 9,96 ± 0,14 8,07 ± 0,17 12,12 ± 0,32 9,87 ± 0,13
K3 10,02 ± 0,15 8,54 ± 0,09 11,93 ± 0,12 10,14 ± 0,15
K4 10,18 ± 0,12 8,85 ± 0,15 7,09 ± 0,15 6,12 ± 0,14
K5 10,00 ± 0,19 10,20 ± 0,14 10,06 ± 0,19 9,90 ± 0,16
Legend. K1: Group injected with tachyzoites and intervered  with C. Longa  dose of  125 mg/kgbb. K2: Group 
injected with tachyzoites and intervered  with C. Longa  dose of  500 mg/kgbb. K3: Group injected with tachyzoites 
and intervered  with Spiramycin  dose of  60 mg/kgbb. K4: Group injected with tachyzoites and intervered  with 
distilled water 0,2 ml. K5: Group  was not injected with tachyzoites and  was not intervered.   A1:one day before 
tachyzoites injection, A2: Three days after tachyzoites injection, A3 and A4 Three and seven days after intervention. 
     
Table 4   TNF-α Level before and after Intervention.
Group
(K)
TNF-α  Level (pg/ml)
A1 A2 A3 A4
K1 36,738 ±  0,015 301,708 ± 0,025 130,23 ± 0,013 81,976 ± 0,010
K2 31,310 ± 0,013 285,244 ± 0,018 144,102 ± 0,013 88,611 ± 0,015
K3 38,219 ± 0,013 305,425 ± 0,017 137,139 ± 0,013 85,870 ±  0,013
K4
35,814± 0,013
292,432 ±  0,020 352,750 ± 0,019 558,436 ± 0,020
K5 36,517 ± 0,008 36,517 ±  0,007 34,410  ±  0,010 36,517 ±  0,005
Legend. K1: Group injected with tachyzoites and intervered  with C. Longa  dose of  125 mg/kgbb. K2: Group 
injected with tachyzoites and intervered  with C. Longa  dose of  500 mg/kgbb. K3: Group injected with tachyzoites 
and intervered  with Spiramycin  dose of  60 mg/kgbb. K4: Group injected with tachyzoites and intervered  with 
distilled water 0,2 ml. K5: Group  was not injected with tachyzoites and  was not intervered.   A1:one day before 
tachyzoites injection, A2: Three days after tachyzoites injection, A3 and A4 Three and seven days after intervention. 
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Discussion 
This study was conducted in mice that were 
conditioned 1-3 days of pregnancy and acute 
toxoplasmosis. The anti-toxoplasma IgG- 
IgM antibody levels increased significantly 3 
days after injection of  T. gondii  tachyzoites 
(Table 1 and 2), it means that the mice  have 
been acute toxoplasmosis before intervention. 
Our previous study also found that anti-
toxoplasma IgM and IgG antibody levels 
increased significantly 24 hours and 48 hours 
after  injection of 10 T. gondii tachyzoites5
The expression of FOXP3 gene in this 
study decreased significantly (p < 0.05) 3 days 
after  injection of 10  T. gondii tachyzoites. 
The other researchers also reported decreased 
the FOXP3 gene expression during acute 
infection9-10.  Three and Seven days after 
intervention with C. longa extract dose of 
125 and 500 mg/kg/days, the FOXP3 gene 
expression increased significantly (p < 0.05), 
however the increased of  FOXP3 gene 
expression in two groups has no significant 
difference. The curcumin can increase the 
expression of the FOXP3 gene through 
the transforming growth factor-β (TGF-β) 
pathway. The curcumin induces conversion 
of peripheral CD4+CD25- naive T cells to 
CD4+CD25+ regulatory T cells by TGF-β 
induction of transcription factor FOXP319  
Several researchers also reported that FOXP3 
gene expression increased 7-day after 
intervention  with curcumin20-21.  
In this study the TNF-α levels increased 
significantly (p <0.01) 3 days after tachyzoites 
injection and decreased significantly (p< 
0.05)  3 and 7 days  after  C. longa  extract 
intervention dose of 125 and 500 mg / kg / 
day, however the decrease of  TNF-α level 
in two groups has no significant difference. 
Guo et al, also reported that TNF-α levels 
increased 7 days after  curcumin intervention 
dose of 100 mg22.
In this study, the histopathology 
examination of placental tissue 7 days after 
intervention with curcuma longa extract 
was not found hemorrhage and necrotic 
cells, but in the positive control group found 
hemorrhagic and necrotic cells were 75% of 
sample and 100% in negative control group. 
Based on the findings this study it can be 
concluded that Curcuma longa extract dose 
of 125 mg / kg /day for 7 days effectively 
to prevent the damage of placental tissue 
cells in early  pregnant mice with acute 
toxoplamosis. Curcuma longa can prevent 
cell damage by increasing foxp3 gene 
expression and decreasing TNF-α levels. The 
use of curcuma longa extract at dose of 125 
Table5. Histological Finding after Intervention
Group
(K)
Histological Finding
Congestive 
Capiler (%)
 Extracellular 
Edema (%)
Haemorrhagic
 (%)
Necrotic cell
(%)
K1 100 50 0 0
K2 100 75 0 0
K3 100 100 75 75
K4 100 100 100 100
 K5 100 0 0 0
Legend. K1: Group injected with tachyzoites and intervered  with C. Longa  dose of  125 mg/kgbb. K2: Group injected with 
tachyzoites and intervered  with C. Longa  dose of  500 mg/kgbb. K3: Group injected with tachyzoites and intervered  with 
Spiramycin  dose of  60 mg/kgbb. K4: Group injected with tachyzoites and intervered  with distilled water 0,2 ml. K5: Group 
was not injected with tachyzoites and  was not intervered.   A1:one day before tachyzoites injection, A2: Three days after 
tachyzoites injection, A3 and A4 Three and seven days after intervention.
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mg / kg / day for 7 days may be considered 
as supportive  therapy in early pregnancy 
with acute toxoplasmosis, however further 
research is needed.
Conclusion 
Curcuma longa extract dose of 125 mg/kg/
day for 7 days orally effective to prevent cells 
damage placental tissue in early pregnant 
mice with acute toxoplamosis. 
References
1. Black MW,  Boothroyd JC.  Lytic Cycle 
of Toxoplasma  Gondii. Microbiol Mol 
Biol Rev.2000; 64(3) : 607−623. 
2. Khan A, Dubey JP, Su C, Ajioka 
JW, Rosenthal BM, Sibley LD. 
Genetic analyses of atypical Toxoplasma 
gondii strains reveal a fourth clonal lineage 
in North America.Int J Parasitol.2011; 
41(6):645−655
3. Wang L, Chen H, Liu D, Huo X, Gao 
J, Song X, et al. Genotypes and Mouse 
Virulence of Toxoplasma gondii Isolates 
from Animals and Humans in China. 
PLoS One. 2013; 8(1): e53483 
4. Kang H, Jack S, Remington, Suzuki Y. 
Decreased resistance of B cell-deficient 
mice to infection with T. gondii despite 
unimpaired expression of IFN-γ, TNF-α, 
and inducible nitric oxide synthase. J 
Immunol. 2000; 164: 2629−2634.
5. Simanjuntak TP, Hatta M, Sirait RH, Karo 
M, Sirait LI, Aritonang TR, et al. Analysis 
concentration of Toxoplasma gondii 
on anti-toxoplasma IgG-IgM antibody 
Levels, and the outcomes of pregnancy 
in mice Balb/c. Open J Obstetric and 
Gynecology.2017; 7: 281−9.
6. Prigione I, Chiesa S, Taverna P, et al. 
T cell mediated immune responses to 
Toxoplasma gondii in pregnant women 
with primary toxoplasmosis. Microbes 
Infect. 2006;8 : 552–560.
7. Fontenot JD, Rasmussen JP, Williams 
LM, Dooley JL, Farr AG, Rudensky AY. 
Regulatory T cell lineage specification by 
the forkhead transcription factor FOXP3. 
Immunity. 2005; 22: 329−41.
8. Cosmi L, Liotta F, Angeli R. Th2 cells 
are less susceptible than Th1 cells to 
the suppressive activity of CD25+ 
regulatory thymocytes because of their 
responsiveness to different cytokines. 
Blood. 2004; 103: 3117–3121.
9. Ge YY, Zhang L, Zhang G, Wu JP, Tan 
MJ, Hu W, et al.  In Pregnant Mice, the 
Infection of Toxoplasma gondii Causes 
the Decrease of CD4+CD25+ Regulatory 
T Cells. Parasite Immunology. 2008; 30: 
471−481.
10. Chen JL, Ge YY, Zhang J, Qiu XY, Qiu 
JF. The dysfungtion of CD4+CD25+ 
regulatory T Cells contributes to the 
abortion of mice caused by Toxoplasma 
gondii excreted- secreted  antigen in 
early pregnancy. PLOS ONE. 2013; 8(7): 
e69012
11. Clark DA,  Ding JW,  Chaouat G, Coulam 
CB,  August C,  Levy GA. The Emerging 
Role of Immunoregulation of Fibrinogen-
Related Procoagulant Fgl2 in the Success 
or Spontaneous Abortion of Early 
Pregnancy in Mice and Humans. Am J 
Repro Immunol. 1999;  42(1): 37−43. 
12. Clark DA, Ding JW, Yu G, Levy GA, 
Gorczynski RM. Fgl 2 protrombinase 
expression in mouse trophoblast 
and  decidua triggers abortion but 
may becountered by OX-2. Mol Hum 
Reprod.2001; 7:185−194. 
13. Haider S, Knofler M. Human tumour 
necrosis factor: physiological and 
pathological roles in placenta and 
endometrium. Placenta. 2009; 
30(2):111−123. 
14. Anggarwal BB, Gupta SC, Sung B. 
Curcumin: an orally bioavailable 
blocker of TNF and other pro-
inflamatory biomarkers. British j of 
177
Tigor Peniel Simanjuntak: Effectiveness Curcuma Longa to Prevent Cells Damage in Early Pregnant Mice
Pharmacology.2013; 169:1672−92.
15. Motterlini R, Oresti R, Bassi R, JGreen 
C. Curcumin, an antioxidant and anti-
inflammatory agent, induces heme 
oxygenase-1 and protects endothelial 
cells against oxidative stress. Free 
Radical Biology and Medicine. 2000; 
8(15): 1303−12.
16. Najia A, Al- Zanbagi. In vivo effect of 
some spices extracts on the Toxoplasma 
gondii  tachyzoites. J Family community 
Med. 2009; 16(2): 59−65.
17. Moghadamtousi SZ, Tajik H, Abubakar 
S, Zandi K. A review on antibacterial, 
antiviral, antifungal activity of kurkumin. 
Biomed Research internasional.2014: 
1−12.
18. Tyagi P, Singh M, Kumari  H, Kumari 
A, Mukhopadhyay. Bacterial activity of 
curcumin  is associated with damaging of 
bacterial membrane. PLOS ONE. 2015; 
10(3): e012313 
19. Chen W, Jin W, Hardegen N, Lei 
KJ,  Li Li, Marinos N. Conversion of 
Periferal CD4+CD25- Naive T Cells 
to CD4+CD25+ Regulatory T Cells by 
TGF-β Induction of Transcription Factor 
FOXP3. J experimental Medicine. 2003; 
198(12): 1875−1886.
20. Cong Y, Wang L,  Konrad A, Ashoeb 
T, Elson CO. Curcumin  Induces the 
Tolerogenic Dendritic Cell that Promotes 
Differentiation of Intestine – Protective 
Regulatory T Cells. Eur.J. Immunol. 
2009; 39:3134−3146.
21. Zhao HM,  Xu R, Huang XY, Cheng 
SM, Huang MF, Yue HY, et al. Curcumin 
Inproves Regulatory T Cells in Gut-
Associated Lymhoid Tissue of Colitis 
Mice.  J Gastroenterol. 2016; 22(23): 
5374−5383.
22. Guo Y-Z World, Ping He, Ai-Min Feng. 
Effect of curcumin on expressions of 
NF-Kb, and IL-8 in placental tissue of 
premature birth of infected mice. Asian 
Pacific Journal of Tropical Medicine. 
2017; 10(2): 175−8.
